Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential cation channel subfamily C member 5 (TRPC5) is a non-selective, calcium-permeant cation channel involved in various physiological processes including cold sensing, pain modulation, and store-operated calcium entry. It is a promising drug target for progressive kidney disease, depression, anxiety disorders, and pain. TRPC5 can form homotetramers or heteromultimers with other TRPC proteins. Its activity is modulated by extracellular reduced thioredoxin, certain anesthetics, and lysophosphatidylcholine (LPC).
Inhibition of TRPC5 channel activity by stabilizing the channel in a closed state.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily C member 5 (TRPC5).